Yangmin Ning - FDA Investigator Report

Designation: PHYSICIAN

Duty Station: Silver Spring MD 20993-0002

Organizations: DHHS FDA CDER OMPT CDER OC OSI DCCE GCPAB

Overview Statistics

8
Total Inspections
2
Total 483s Issued
0
Warning Letters Issued

Inspection Details

Longest Inspection: 12 days
Shortest Inspection: 3 days
Average Length: 6.1 days

Discover the bigger picture. This is just the tip of the iceberg.

Gain access to comprehensive analysis, detailed reports, AI assistant, and much more.

Schedule a Demo

Yangmin Ning's Recent Inspections

DateCompanyCityCountryFEI Number483
2022-11-16XERIS PHARMACEUTICALS INCChicagoUnited States3014193489
2022-07-15Daiichi Sankyo Inc.Basking RidgeUnited States3003089536
2020-10-27AstraZeneca Pharmaceuticals LPGaithersburgUnited States1000198729
2019-09-27Ming-Shen Dai, M.D., Ph.D.Taipei CityTaiwan3015527810
2019-05-24Puma Biotechnology, Inc.Los AngelesUnited States3011065073
2019-05-03Median TechnologiesValbonneFrance3005312556
2019-01-25Eli Lilly & CompanyIndianapolisUnited States1819470
2018-11-30Janssen Biotech, Inc.MalvernUnited States3001610451

Sign Up to get the complete report.

Download 483s and EIRs for Yangmin Ning

Yangmin Ning - Co-Inspectors

NameInspectionsLast Inspection
Lynda L Lanning12022
Jeanne J Thai12022
Michael Serrano12022
Lee Hong Pai Scherf12020
David L Chon12020
Ni A Khin12019
Karen M Cooper12019
Corrine M Carter12019
Richard W Berning12019
Angela Shepas12019
Anastasia I Offordile12018

Yangmin Ning's Active Locations

  • United States
  • France
  • Taiwan

Yangmin Ning's Year-wise Inspection Count

  • 2018:1 inspections
  • 2019:4 inspections
  • 2020:1 inspections
  • 2022:2 inspections
Last Updated: 2025-05-14 06:11:22